Tuesday, February 17, 2015 2:05:02 PM
And yes - that does seem to be the MO for the FDA,.... err always on the side of caution.
Don't get me wrong - I would rather have the FDA there to act as an arbitrator / monitor of proposed treatments than not - but they do often seem to be as much a barrier to progress as a shepherd for good drugs/treatments.
Have only been watching HEB since I first heard about the successful tests against Ebola back last November, and have only been a shareholder here since the day after announcing the mouse efficacy test results (the day price shot back down - lucky for me),.... and am still in the learning & DD phase here with my first vested stake.
Will be looking to add shares as cash becomes available, and assuming that further progress is made by HEB.
And - in the long run - anything that might have a positive effect on people suffering from CFS (have a friend of my wife's family who has been dealing with it for a decade or more) is probably going to be beneficial for patients, and profitable for me.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM